BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang Y, Feng B, Zhang GL, Hu M, Fu Z, Zhao F, Zhang XL, Kong L, Yu JM. Value of 18F-FDG PET-CT in surveillance of postoperative colorectal cancer patients with various carcinoembryonic antigen concentrations. World J Gastroenterol 2014; 20(21): 6608-6614 [PMID: 24914384 DOI: 10.3748/wjg.v20.i21.6608]
URL: https://www.wjgnet.com/1007-9327/full/v20/i21/6608.htm
Number Citing Articles
1
Majid Assadi. Clinical Nuclear Medicine2020; : 597 doi: 10.1007/978-3-030-39457-8_19
2
WENZHE BU, RAN WEI, JINPENG LI, LIJUN WANG, CONGCONG SHI, JINLONG SONG, SHUANGSHUANG MA, HUA CHEN, NING CONG. Association between carcinoembryonic antigen levels and the applied value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative recurrent and metastatic colorectal cancerOncology Letters 2014; 8(6): 2649 doi: 10.3892/ol.2014.2523
3
Secondo Lastoria, Luigi Aloj, Corradina Caracò, Raffaele Farese, Anna Morisco. Multimodal Treatment of Recurrent Pelvic Colorectal CancerUpdates in Surgery 2016; : 39 doi: 10.1007/978-88-470-5767-8_4
4
Yun Hee Kang, Eunji Han, Geon Park. Clinical Etiology of Hypermetabolic Pelvic Lesions in Postoperative Positron Emission Tomography/Computed Tomography for Patients With Rectal and Sigmoid CancerAnnals of Coloproctology 2018; 34(2): 78 doi: 10.3393/ac.2017.09.21
5
Nivine Abdel Moneim Chalabi, Reem Hassan Bassiouny, Mohamed Abobakr El Sedek. FDG-PETCT versus contrast-enhanced computed tomography in diagnosis of post-therapeutic colorectal cancer recurrence and metastasesEgyptian Journal of Radiology and Nuclear Medicine 2020; 51(1) doi: 10.1186/s43055-019-0083-y
6
Zaiba Shafik Dawood, Laura Alaimo, Henrique A. Lima, Zorays Moazzam, Chanza Shaikh, Ahmed Sayed Ahmed, Muhammad Musaab Munir, Yutaka Endo, Timothy M. Pawlik. Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen: Comparison of Surveillance Strategies Among Patients Who Underwent Resection of Colorectal Cancer—A Systematic Review and Meta-analysisAnnals of Surgical Oncology 2023; 30(1): 259 doi: 10.1245/s10434-022-12641-7
7
Giuseppe Antonio Colloca, Antonella Venturino, Domenico Guarneri. Carcinoembryonic antigen reduction after medical treatment in patients with metastatic colorectal cancer: a systematic review and meta-analysisInternational Journal of Colorectal Disease 2019; 34(4): 657 doi: 10.1007/s00384-018-03230-w
8
Wu Cai-Xia, Wang Rong-Fu. Clinical application and research advancement of positron emission tomography/computed tomography in colorectal cancerWorld Chinese Journal of Digestology 2020; 28(18): 925 doi: 10.11569/wcjd.v28.i18.925
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
9
M. Rodríguez-Fraile, M.P. Cózar-Santiago, A. Sabaté-Llobera, A.P. Caresia-Aróztegui, R.C. Delgado Bolton, J. Orcajo-Rincon, M. de Arcocha-Torres, M.J. García-Velloso, P. García-Talavera. FDG PET/TC en el cáncer colorrectalRevista Española de Medicina Nuclear e Imagen Molecular 2020; 39(1): 57 doi: 10.1016/j.remn.2019.09.009
10
Jiali Yao, Song Zhang, Jingyan Liang, Hongliang Li. The diagnostic performance of 2-[18F]FDG PET/CT for the recurrent colorectal cancer in patients with elevated CEA versus normal CEA: a systematic review and meta-analysisClinical and Translational Imaging 2022; 11(2): 209 doi: 10.1007/s40336-022-00536-2
11
M. Rodríguez-Fraile, M.P. Cózar-Santiago, A. Sabaté-Llobera, A.P. Caresia-Aróztegui, R.C. Delgado-Bolton, J. Orcajo-Rincon, M. de Arcocha-Torres, M.J. García-Velloso, P. García-Talavera. FDG PET/CT in colorectal cancerRevista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2020; 39(1): 57 doi: 10.1016/j.remnie.2019.12.001
12
Vincent Vinh-Hung, Hendrik Everaert, Karim Farid, Navid Djassemi, Jacqueline Baudin-Veronique, Stefanos Bougas, Yuriy Michailovich, Clarisse Joachim-Contaret, Elsa Cécilia-Joseph, Claire Verschraegen, Nam P Nguyen. Preoperative [18]fluorodeoxyglucose-positron emission tomography/computed tomography in early stage breast cancer: Rates of distant metastasesWorld Journal of Radiology 2017; 9(7): 312-320 doi: 10.4329/wjr.v9.i7.312
13
Charles Marcus, Wael Marashdeh, Se Jin Ahn, Mehdi Taghipour, Rathan M. Subramaniam. 18F-FDG PET/CT and Colorectal Cancer: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient ManagementJournal of Nuclear Medicine 2015; 56(7): 989 doi: 10.2967/jnumed.115.156240
14
Sander Thomas Laurens, Wim J.G. Oyen. Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal CancerPET Clinics 2015; 10(3): 345 doi: 10.1016/j.cpet.2015.03.007
15
Charles Marcus, Rick Wray, Mehdi Taghipour, Wael Marashdeh, Se Jin Ahn, Esther Mena, Rathan M. Subramaniam. JOURNAL CLUB: Value of Quantitative FDG PET/CT Volumetric Biomarkers in Recurrent Colorectal Cancer Patient SurvivalAmerican Journal of Roentgenology 2016; 207(2): 257 doi: 10.2214/AJR.15.15806
16
Dimitrios Priftakis, Saima Riaz, Francesco Fraioli. Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology2021; : 37 doi: 10.1007/978-3-030-68858-5_5
17
Bhasker R. Koppula, Gabriel C. Fine, Ahmed Ebada Salem, Matthew F. Covington, Richard H. Wiggins, John M. Hoffman, Kathryn A. Morton. PET-CT in Clinical Adult Oncology: III. Gastrointestinal MalignanciesCancers 2022; 14(11): 2668 doi: 10.3390/cancers14112668
18
Waleed Hetta, Gamal Niazi, Mohammed H. Abdelbary. Accuracy of 18F-FDG PET/CT in monitoring therapeutic response and detection of loco-regional recurrence and metastatic deposits of colorectal cancer in comparison to CTEgyptian Journal of Radiology and Nuclear Medicine 2020; 51(1) doi: 10.1186/s43055-020-00151-z
19
Levent Ugurlu. Colon Polyps and Colorectal Cancer2021; : 419 doi: 10.1007/978-3-030-57273-0_21
20
Brian C. Wilson, Donovan Eu. Optical spectroscopy and imaging in surgical management of cancer patientsTranslational Biophotonics 2022; 4(3) doi: 10.1002/tbio.202100009